Dual incretin agonist: difference between revisions
Diff·revision 31 → 32·01:06, 2 Mar 2026
Difference between revision 31 and revision 32 of Dual incretin agonist. This revision changed no lines of source — the edit was a null or whitespace change.
| Revision 31 — 16:11, 29 Jan 2026 HyphenHarriet (talk) attribute the potency comparison to the head-to-head trial rather than to two separate ones 5,851 bytes ±0 | Revision 32 — 01:06, 2 Mar 2026 MTC_Marisol (talk) add the discontinued indication with its date 5,851 bytes ±0 | ||
|---|---|---|---|
| — | No change to the page source. | — |